UC recognizes students for innovation achievement and leadership
Team efforts impact industry and the university
On April 4, 2024, the University of Cincinnati’s NEXT Innovation Scholars program, along with the College of Cooperative Education and Professional Studies, recognized undergraduate students with the new Neil Armstrong Awards for Transdisciplinary Innovation and Impact.
The awards are in two categories: commercial innovation and innovation leadership.
Neil Armstrong Moonshot Award for Commercial Innovation
Seven UC students with representatives of Kao and its luxury beauty brand Molton Brown at the company's New York City offices. Photo/provided
The Neil Armstrong Moonshot Award for Commercial Innovation is awarded annually to a transdisciplinary team of students who demonstrate exemplary work in driving commercial innovation through collaboration with an industry partner from the Cincinnati Innovation District.
This year’s award went to a diverse team made up of the following students:
- Eliza Angelo, senior, business analytics, operations management and international business
- Jackie Cunningham, sophomore, industrial design
- Mallika Desa, junior, medical sciences
- Sophia Lammi, sophomore, fashion design and French
- Sharvari Patil, sophomore, marketing and information systems
- Faith Rider, third-year, computer science
- Gabe Willard, junior, architecture
They were selected for their work discovering and activating unique applications of generative AI in collaboration with Kao Corporation. The team was sought out to research, test and apply generative AI’s potential in the luxury beauty category.
The student team's work - in collaboration with a London-based team from beauty brand Molton Brown - led to the development of a novel approach to leveraging AI for consumer insights, culminating with a presentation to senior leaders in New York City and a follow-up project with more divisions of Molton Brown to further the team’s initial work.
Neil Armstrong New Frontiers Award for Innovation Leadership
Students Akash Khanikor (left) and Jonathan Raj (right) have been leaders in innovation at UC. Photo/provided
The Neil Armstrong New Frontiers Award for Innovation Leadership is awarded annually to an individual or team whose leadership of innovation initiatives or projects empowers and elevates others in the University of Cincinnati innovation ecosystem to reach new levels of innovation potential.
This year’s award went to the team of Akash Khanikor, a senior studying physics with an economics minor, and Jonathan Raj, a senior in biomedical engineering.
Raj and Khanikor are being recognized for their work to advance strategic foresight and futures research at UC. Over several semesters, they have sought increasing levels of responsibility and leadership, including serving as peer leaders for more than 20 students on various research teams. They also played key roles in the publication of the first annual Future Creators research publication, released in December 2023.
Featured image at top: A University of Cincinnati student closely examines a complex model structure. Photo/UC Marketing + Brand
Next Lives Here
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.